Metoprolol Succinate Tablet, Extended Release
Product Images NDC 69097-409

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 69097-409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B6d50141 4598 4f04 B407 08df00bf4537 01

Chemical structure of metoprolol succinate, showing its molecular components including aromatic ring, hydroxyl, ether, amine groups, and succinate acid moiety.*

FDA Label Image

B6d50141 4598 4f04 B407 08df00bf4537 02

A forest plot presenting results for subgroups in the MERIT-HF study comparing metoprolol succinate extended-release tablets versus placebo. It shows relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. Subgroups include geographic region, NYHA class, ejection fraction, etiology, sex, race, history of myocardial infarction, diabetes, hypertension, and heart rate.*

FDA Label Image

B6d50141 4598 4f04 B407 08df00bf4537 03

Label for Metoprolol Succinate Extended-Release Tablets, USP 50 mg, provided by Cipla USA Inc. The label indicates 100 tablets per package. It includes dosage strength details, storage instructions at controlled room temperature, and a caution to verify the product dispensed. The product is for prescription use only.*

FDA Label Image

B6d50141 4598 4f04 B407 08df00bf4537 04

Label for Metoprolol Succinate extended-release tablets, USP, 100 mg strength. The label includes dosage form and strength, quantity of 100 tablets, and highlights the manufacturer as Cipla USA Inc. It also features storage instructions, warnings, and a caution to verify the product dispensed. The NDC number and barcode are visible on the right side.*

FDA Label Image

B6d50141 4598 4f04 B407 08df00bf4537 05

Metoprolol Succinate Extended-Release Tablets, USP 200 mg, oral tablet, extended-release, in a 100 tablet package. Label shows Cipla as the manufacturer and Cipla USA, Inc. as the labeler. Label includes dosage form, strength, manufacturer address, storage instructions, and a caution to verify the product dispensed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.